English

CHEMOKINE THERAPEUTICS CORP

EDGAR

Quarterly report (10-Q) · filed 2008-11-10

17 filing records in this dataset, filed from 2004-12-30 to 2008-11-10. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2008-03-31 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-899 thousand USD

2008-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -899342 USD Source

Free cash flow

-900 thousand USD

2008-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -899342 USD Source
Capital Expenditure: 799 USD Source

Cash and cash equivalents: 733 thousand USD 2008-03-31 Source
Exact value

733031 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2008-11-10.

Financial data available through: 2007-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2007-12-31
operating income: No compatible figures in this window
Net income: 4 of 11 periods available· newest 2007-12-31
Operating cash flow: 2 of 11 periods available· newest 2007-12-31
Capital expenditure: 4 of 11 periods available· newest 2007-12-31
Total assets: 1 of 11 periods available· newest 2004-12-31
liabilities: No compatible figures in this window
Current assets: 4 of 11 periods available· newest 2007-12-31
Current liabilities: 4 of 11 periods available· newest 2007-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2007-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
0%

Prior period

USD 275,000

2006-01-01 – 2006-12-31
Current period

USD 275,000

2007-01-01 – 2007-12-31

Exact inputs and evidence

275000 − 275000 = 0 USD

275000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
275000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CHEMOKINE THERAPEUTICS CORP · 2007-12-31 CHEMOKINE THERAPEUTICS CORP (edgar:1092959) Year-over-year change in Revenue: 0 USD Concept: fundies:Revenue Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:14:32Z Snapshot: 087151d00203f55e8d536a1a852e832d1f17e13a3e225fea07eea3532f092241 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092959?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 275000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-08-000436.txt#2859 Input fundies:Revenue: 275000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-07-000231.txt#2063
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 6.24 million

Prior period

−USD 24.54 million

2006-01-01 – 2006-12-31
Current period

−USD 30.78 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

-30783298 − -24543412 = -6239886 USD

-24543412 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
-30783298 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CHEMOKINE THERAPEUTICS CORP · 2007-12-31 CHEMOKINE THERAPEUTICS CORP (edgar:1092959) Year-over-year change in Net income: -6239886 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:14:32Z Snapshot: 087151d00203f55e8d536a1a852e832d1f17e13a3e225fea07eea3532f092241 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092959?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -30783298 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-08-000436.txt#3967 Input fundies:NetIncome: -24543412 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-07-000231.txt#3220
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 5.12 million

Prior period

−USD 21.86 million

2006-01-01 – 2006-12-31
Current period

−USD 26.99 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

-26988490 − -21864686 = -5123804 USD

-21864686 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
-26988490 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CHEMOKINE THERAPEUTICS CORP · 2007-12-31 CHEMOKINE THERAPEUTICS CORP (edgar:1092959) Year-over-year change in Operating cash flow: -5123804 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:14:32Z Snapshot: 087151d00203f55e8d536a1a852e832d1f17e13a3e225fea07eea3532f092241 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092959?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -26988490 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-08-000436.txt#4038 Input fundies:OperatingCashFlow: -21864686 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-07-000231.txt#3282
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+56.4%

Prior period

USD 643,881

2006-01-01 – 2006-12-31
Current period

USD 1.01 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

1006919 − 643881 = 363038 USD

643881 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
1006919 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CHEMOKINE THERAPEUTICS CORP · 2007-12-31 CHEMOKINE THERAPEUTICS CORP (edgar:1092959) Year-over-year change in Capital expenditure: 363038 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:14:32Z Snapshot: 087151d00203f55e8d536a1a852e832d1f17e13a3e225fea07eea3532f092241 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092959?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1006919 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-08-000436.txt#4113 Input fundies:CapitalExpenditure: 643881 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-07-000231.txt#3344
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2007-01-01 – 2007-12-31

Revenue USD 275,000 100% of revenue
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income −USD 30.78 million −11,194% of revenue

Cash

Operating cash flow −USD 26.99 million −9,814% of revenue
Capital expenditure USD 1.01 million 366% of revenue
Free cash flow Derived −USD 28 million −10,180% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2004 Not shown: operating income or net income is not reported.
2005 Not shown: operating income or net income is not reported.
2006 Not shown: operating income or net income is not reported.
2007 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2004 2004-01-01 – 2004-12-31	0	Unavailable	Unavailable	Unavailable	-11015380	Unavailable	Source 2004-01-01 – 2004-12-31: 0 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -11015380 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: 145682 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	275000	Unavailable	Unavailable	Unavailable	-17035546	Unavailable	Source 2005-01-01 – 2005-12-31: 275000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -17035546 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: 489529 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	275000	Unavailable	Unavailable	Unavailable	-24543412	-22508567 Derived	Source 2006-01-01 – 2006-12-31: 275000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -24543412 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -21864686 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 643881 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	275000	Unavailable	Unavailable	Unavailable	-30783298	-27995409 Derived	Source 2007-01-01 – 2007-12-31: 275000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -30783298 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -26988490 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 1006919 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 275K 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Revenue	0	Revenue: 0 Open source
20052005-12-31	Revenue	275000	Revenue: 275000 Open source
20062006-12-31	Revenue	275000	Revenue: 275000 Open source
20072007-12-31	Revenue	275000	Revenue: 275000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

0% 2007

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20052005-12-31	Year over year	No prior comparable period	Revenue: 275000 Open source Revenue: 0 Open source
20062006-12-31	Year over year	0%	Revenue: 275000 Open source Revenue: 275000 Open source
20072007-12-31	Year over year	0%	Revenue: 275000 Open source Revenue: 275000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Net margin -11,193.9% 2007

Free cash flow margin -10,180.1% 2007

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2004-12-31	Operating margin	Not reported	Revenue: 0 Open source
2005-12-31	Operating margin	Not reported	Revenue: 275000 Open source
2006-12-31	Operating margin	Not reported	Revenue: 275000 Open source
2007-12-31	Operating margin	Not reported	Revenue: 275000 Open source
20042004-12-31	Net margin	Not reported	Net Income: -11015380 Open source Revenue: 0 Open source
20052005-12-31	Net margin	-6,194.7%	Net Income: -17035546 Open source Revenue: 275000 Open source
20062006-12-31	Net margin	-8,924.9%	Net Income: -24543412 Open source Revenue: 275000 Open source
20072007-12-31	Net margin	-11,193.9%	Net Income: -30783298 Open source Revenue: 275000 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Capital Expenditure: 145682 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 275000 Open source Capital Expenditure: 489529 Open source
20062006-12-31	Free cash flow margin	-8,184.9%	Revenue: 275000 Open source Operating Cash Flow: -21864686 Open source Capital Expenditure: 643881 Open source
20072007-12-31	Free cash flow margin	-10,180.1%	Revenue: 275000 Open source Operating Cash Flow: -26988490 Open source Capital Expenditure: 1006919 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -27M 2007

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Operating cash flow	Not reported	No source recorded
20052005-12-31	Operating cash flow	Not reported	No source recorded
20062006-12-31	Operating cash flow	-21864686	Operating Cash Flow: -21864686 Open source
20072007-12-31	Operating cash flow	-26988490	Operating Cash Flow: -26988490 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -28M 2007

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Free cash flow	Unavailable	Capital Expenditure: 145682 Open source
20052005-12-31	Free cash flow	Unavailable	Capital Expenditure: 489529 Open source
20062006-12-31	Free cash flow	-22508567	Operating Cash Flow: -21864686 Open source Capital Expenditure: 643881 Open source
20072007-12-31	Free cash flow	-27995409	Operating Cash Flow: -26988490 Open source Capital Expenditure: 1006919 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2004-12-31	Liabilities / assets	Not reported	Total Assets: 11551248 Open source
2005-12-31	Liabilities / assets	Not reported	No source recorded
2006-12-31	Liabilities / assets	Not reported	No source recorded
2007-12-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

0.92× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Current assets / current liabilities	12.58×	Current Assets: 11499936 Open source Current Liabilities: 914489 Open source
20052005-12-31	Current assets / current liabilities	24.68×	Current Assets: 6535106 Open source Current Liabilities: 264847 Open source
20062006-12-31	Current assets / current liabilities	16.02×	Current Assets: 6253158 Open source Current Liabilities: 390307 Open source
20072007-12-31	Current assets / current liabilities	0.92×	Current Assets: 832521 Open source Current Liabilities: 908250 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2004 2004-01-01 – 2004-12-31	−USD 11.02 million Exact value Exact value: -11015380 USD 2004-01-01 – 2004-12-31: -11015380 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHEMOKINE THERAPEUTICS CORP · 2004-12-31 CHEMOKINE THERAPEUTICS CORP (edgar:1092959) Net Income: -11015380 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:14:32Z Snapshot: 087151d00203f55e8d536a1a852e832d1f17e13a3e225fea07eea3532f092241 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092959/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11015380 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-05-000091.txt#2274 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 145,682 Exact value Exact value: 145682 USD 2004-01-01 – 2004-12-31: 145682 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHEMOKINE THERAPEUTICS CORP · 2004-12-31 CHEMOKINE THERAPEUTICS CORP (edgar:1092959) Capital Expenditure: 145682 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:14:32Z Snapshot: 087151d00203f55e8d536a1a852e832d1f17e13a3e225fea07eea3532f092241 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092959/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 145682 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-05-000091.txt#2432 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2005 2005-01-01 – 2005-12-31	−USD 17.04 million Exact value Exact value: -17035546 USD 2005-01-01 – 2005-12-31: -17035546 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHEMOKINE THERAPEUTICS CORP · 2005-12-31 CHEMOKINE THERAPEUTICS CORP (edgar:1092959) Net Income: -17035546 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:14:32Z Snapshot: 087151d00203f55e8d536a1a852e832d1f17e13a3e225fea07eea3532f092241 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092959/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17035546 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-06-000156.txt#2714 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 489,529 Exact value Exact value: 489529 USD 2005-01-01 – 2005-12-31: 489529 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHEMOKINE THERAPEUTICS CORP · 2005-12-31 CHEMOKINE THERAPEUTICS CORP (edgar:1092959) Capital Expenditure: 489529 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:14:32Z Snapshot: 087151d00203f55e8d536a1a852e832d1f17e13a3e225fea07eea3532f092241 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092959/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 489529 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-06-000156.txt#2851 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2006 2006-01-01 – 2006-12-31	−USD 24.54 million Exact value Exact value: -24543412 USD 2006-01-01 – 2006-12-31: -24543412 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHEMOKINE THERAPEUTICS CORP · 2006-12-31 CHEMOKINE THERAPEUTICS CORP (edgar:1092959) Net Income: -24543412 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:14:32Z Snapshot: 087151d00203f55e8d536a1a852e832d1f17e13a3e225fea07eea3532f092241 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092959/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24543412 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-07-000231.txt#3220 The citation records this snapshot. The page link may show a newer release later.	−USD 21.86 million Exact value Exact value: -21864686 USD 2006-01-01 – 2006-12-31: -21864686 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHEMOKINE THERAPEUTICS CORP · 2006-12-31 CHEMOKINE THERAPEUTICS CORP (edgar:1092959) Operating Cash Flow: -21864686 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:14:32Z Snapshot: 087151d00203f55e8d536a1a852e832d1f17e13a3e225fea07eea3532f092241 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092959/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21864686 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-07-000231.txt#3282 The citation records this snapshot. The page link may show a newer release later.	USD 643,881 Exact value Exact value: 643881 USD 2006-01-01 – 2006-12-31: 643881 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHEMOKINE THERAPEUTICS CORP · 2006-12-31 CHEMOKINE THERAPEUTICS CORP (edgar:1092959) Capital Expenditure: 643881 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:14:32Z Snapshot: 087151d00203f55e8d536a1a852e832d1f17e13a3e225fea07eea3532f092241 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092959/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 643881 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-07-000231.txt#3344 The citation records this snapshot. The page link may show a newer release later.	−USD 22.51 million Calculation and evidence -21864686 − 643881 USD Exact free cash flow: -22508567 USD 2006-01-01 – 2006-12-31: -21864686 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 643881 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHEMOKINE THERAPEUTICS CORP · 2006-12-31 CHEMOKINE THERAPEUTICS CORP (edgar:1092959) Free cash flow: -22508567 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:14:32Z Snapshot: 087151d00203f55e8d536a1a852e832d1f17e13a3e225fea07eea3532f092241 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092959?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21864686 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-07-000231.txt#3282 Input fundies:CapitalExpenditure: 643881 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-07-000231.txt#3344 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 30.78 million Exact value Exact value: -30783298 USD 2007-01-01 – 2007-12-31: -30783298 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHEMOKINE THERAPEUTICS CORP · 2007-12-31 CHEMOKINE THERAPEUTICS CORP (edgar:1092959) Net Income: -30783298 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:14:32Z Snapshot: 087151d00203f55e8d536a1a852e832d1f17e13a3e225fea07eea3532f092241 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092959/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -30783298 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-08-000436.txt#3967 The citation records this snapshot. The page link may show a newer release later.	−USD 26.99 million Exact value Exact value: -26988490 USD 2007-01-01 – 2007-12-31: -26988490 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHEMOKINE THERAPEUTICS CORP · 2007-12-31 CHEMOKINE THERAPEUTICS CORP (edgar:1092959) Operating Cash Flow: -26988490 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:14:32Z Snapshot: 087151d00203f55e8d536a1a852e832d1f17e13a3e225fea07eea3532f092241 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092959/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -26988490 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-08-000436.txt#4038 The citation records this snapshot. The page link may show a newer release later.	USD 1.01 million Exact value Exact value: 1006919 USD 2007-01-01 – 2007-12-31: 1006919 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHEMOKINE THERAPEUTICS CORP · 2007-12-31 CHEMOKINE THERAPEUTICS CORP (edgar:1092959) Capital Expenditure: 1006919 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:14:32Z Snapshot: 087151d00203f55e8d536a1a852e832d1f17e13a3e225fea07eea3532f092241 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092959/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1006919 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-08-000436.txt#4113 The citation records this snapshot. The page link may show a newer release later.	−USD 28 million Calculation and evidence -26988490 − 1006919 USD Exact free cash flow: -27995409 USD 2007-01-01 – 2007-12-31: -26988490 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 1006919 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHEMOKINE THERAPEUTICS CORP · 2007-12-31 CHEMOKINE THERAPEUTICS CORP (edgar:1092959) Free cash flow: -27995409 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:14:32Z Snapshot: 087151d00203f55e8d536a1a852e832d1f17e13a3e225fea07eea3532f092241 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1092959?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -26988490 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-08-000436.txt#4038 Input fundies:CapitalExpenditure: 1006919 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1092959/0001176256-08-000436.txt#4113 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

17 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001092959, 1092959, edgar:1092959

CHEMOKINE THERAPEUTICS CORP

Latest quarter

Revenue

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2007 2007-01-01 – 2007-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation